Intravenous and oral administration of amiodarone for the treatment of recent onset atrial fibrillation after digoxin administration

International Journal of Cardiology

Volumn 121, Issue 3, 2007, Pages 291-295

  Xanthos, Theodoros ^a,c   Bassiakou, Eleni ^a,b   Vlachos, Ioannis S ^a   Bassiakos, Sotirios ^a   Michalakis, Konstantinos ^d   Moutzouris, Dimitris Anestis ^e   Papadimitriou, Lila ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGIA OLGA HOSPITAL   (Greece)

^c Kingston General Hospital   (Greece)

^d HELENA VENIZELOU HOSPITAL   (Greece)

^e EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Amiodarone; Atrial fibrillation; Blood pressure; Intravenous; Oral

Indexed keywords

AMIODARONE; DIGOXIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BRADYCARDIA; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PHLEBITIS; PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BLOOD PRESSURE; DIGOXIN; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 34548831931     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.02.024     Document Type: Article

References (33)

1. Prystowsky E.N., Benson Jr. D.W., Fuster V., et al. Management of patients with atrial fibrillation: a statement for healthcare professionals from the subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 93 (1996) 1262-1277
2. Podric P.J. Amiodarone reevaluation of an old drug. Ann Intern Med 122 (1995) 689-700
3. Khan I.A., Mehta N.J., and Gowda R.M. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol 89 (2003) 239-248
4. Andrivent P., Boubakri E., Dove P.J., Mach V., and Vu Ngoc C. A clinical study of amiodarone as a single oral dose in patients with recent-onset atrial tachyarrhythmia. Eur Heart J 15 (1994) 1396-1402
5. Galve E., Rius T., Ballester R., et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation. Results of a randomized controlled study. J Am Coll Cardiol 27 (1996) 1079-1082
6. Falk R.H., Knowlton A.A., Bernard S.A., Gotlieb N.E., and Battinelli N.J. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm: a randomized double-blind trial. Ann Intern Med 106 (1987) 503-506
7. Chapman M.J., Moran J.L., O'Fathartaigh M.S., Peisach A.R., and Cunningham D.N. Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone. Intensive Care Med 19 (1993) 48-52
8. Cybulski J., Kulakowski P., Makowska E., Czepiel A., Sikora-Frac M., and Ceremuzynski L. Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias. Clin Cardiol 19 (1996) 563-566
9. Clemo H.F., Wood M.A., Gilligan D.M., and Ellenbogen K.A. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol 81 (1998) 594-598
10. Cowan J.C., Gardiner P., Reid D.S., Newell D.J., and Campbell R.W. A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected myocardial infarction. J Cardiovasc Pharmacol 8 (1986) 252-256
11. Kreiss Y., Sidi Y., and Gur H. Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: experience in patients admitted to a general internal medicine department. Postgrad Med J 75 (1999) 278-281
12. Peuhkurinen K., Niemela M., Ylitalo A., Linnaluoto M., Lilja M., and Juvonen J. Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation. Am J Cardiol 85 (2000) 462-465
13. Donovan K.D., Power B.M., Hockings B.E., Dobb G.J., and Lee K.Y. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 75 (1995) 693-697
14. Capucci A., Lenzi T., Boriani G., et al. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 70 (1992) 69-72
15. Kochiadakis G.E., Igoumenidis N.E., Simantirakis E.N., et al. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study. Pacing Clin Electrophysiol 21 Pt II (1998) 2475-2479
16. Vardas P.E., Igoumenidis N.E., Simantirakis E.N., et al. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized controlled study. Chest 117 (2000) 1538-1545
17. Khan I.A., Nair C.K., Singh N., Gowda R.M., and Nair R.C. Acute ventricular rate control in atrial fibrillation and atrial flutter. Int J Cardiol 97 (2004) 7-13
18. Tsikouris J.P., and Cox C.D. A review of class III antiarrhythmic agents for AF: maintenance of normal sinus rhythm. Pharmacotherapy 21 (2001) 1514-1529
19. VerNooy R.A., and Mounsey J.P. Antiarrhythmic drug therapy of atrial fibrillation. Cardiol Clin 22 (2004) 21-34
20. Chow M.S. Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use. Ann Pharmacother 30 (1996) 637-643
21. Roden D.M. Current status of class III antiarrhythmic drug therapy. Am J Cardiol 72 (1993) 44B-49B
22. Zehender M., Hohnloser S., Muller B., Meinertz T., and Just H. Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow up. J Am Coll Cardiol 19 (1992) 1054-1059
23. Talajic M., DeRoode M.R., and Nattel S. Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite. Circulation 75 (1987) 265-271
24. Connolly S.J., Latini R., and Kates R.E. Pharmacodynamics of intravenous amiodarone in the dog. J Cardiovasc Pharmacol 6 (1984) 531-535
25. Yabek S.M., Kato R., and Singh B.N. Effect of amiodarone and its metabolite, desethylamiodarone, on the electrophysiologic properties of isolated cardiac muscle. J Cardiovasc Pharmacol 8 (1986) 197-201
26. Naccarelli G.V., Wolbrette D.L., Khan M., et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol 91 (2003) 15D-26D
27. Hofmann R., Steinwender C., Kammler J., Kypta A., and Leisch F. Effect of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate. Int J Cardiol 110 (2006) 27-32
28. Kosinski E.J., Albin J.B., Young E., Lewis S.M., and LeLand Jr. O.S. Hemodynamic effects of intravenous amiodarone. J Am Coll Cardiol 4 (1984) 565-570
29. Ammar A., Wong M., and Singh B.N. Divergent effects of chronic amiodarone administration on systolic and diastolic function in patients with heart disease. Am J Cardiol 75 (1995) 465-469
30. Delle Karth G., Geppert A., Neunteufl T., et al. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 29 (2001) 1149-1153
31. Martinez-Marcos F.J., Garcia-Garmendia L.J., Ortega-Caprio A., Fernandez-Gomez J.M., Sandos J.M., and Camacho C. Title comparison of intravenous fleicanide, propaferone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol 86 (2000) 950-953
32. Ward G.H., and Yalkowsky S.H. Studies in phlebitis. IV: injection rate and amiodarone-induced phlebitis. J Parenter Sci Technol 47 (1993) 40-43
33. Ramus G.V., Veglio F., Bonino M.L., and Tonda L. Amiodarone and its infusion velocity in recent-onset atrial fibrillation. G Ital Cardiol 21 (1991) 1083-1091